128 results
Page 5 of 7
8-K
EX-10.2
pwoc2uzs qny
2 Nov 17
Nemus Bioscience Announces $2,000,000 Series F Preferred Stock Financing
12:00am
8-K
EX-10.1
suwh c2ko36
2 Nov 17
Nemus Bioscience Announces $2,000,000 Series F Preferred Stock Financing
12:00am
424B3
EX-10.2
hxqule
2 Nov 17
Prospectus supplement
12:00am
424B3
EX-10.1
wb5 38pryjby5f511v5e
12 May 17
Prospectus supplement
12:00am
8-K
EX-10.1
dvfiu4 2f
4 May 17
Nemus Bioscience Announces $20 Million Series E
12:00am
8-K/A
EX-10.1
fumld3 i5c3h76f0
20 Jan 17
Financial Statements and Exhibits
12:00am
424B3
EX-10
gr40natjz6ftfm
20 Jan 17
Prospectus supplement
12:00am
424B3
EX-10.1
71qnptlwop2x
20 Jan 17
Prospectus supplement
12:00am
8-K
EX-10.1
5k60je8mp611tiy
10 Jan 17
NEMUS Bioscience Announces Closing of $1,200,000 Preferred Stock Financing
12:00am
8-K
EX-10.2
sks1eylcw2q4m
29 Dec 16
Nemus Bioscience Announces Preferred Stock Financing
12:00am
8-K
EX-10.1
io9ni28gga8cxofj31
29 Dec 16
Nemus Bioscience Announces Preferred Stock Financing
12:00am
424B3
EX-10.1
bgu oe1ctrrgn31g0
28 Oct 16
Prospectus supplement
12:00am
8-K
EX-10.1
q5okgs2
27 Oct 16
NEMUS Bioscience Announces Closing of $500,000 Preferred Stock Financing
12:00am
8-K
EX-10.2
xwl4 wvh1
26 Oct 16
NEMUS Bioscience Announces $500,000 Preferred Stock Financing
12:00am
8-K
EX-10.1
joep4 tmgv2ao5d8ugbp
26 Oct 16
NEMUS Bioscience Announces $500,000 Preferred Stock Financing
12:00am
8-K
EX-10.2
ft93hs 55i
18 Dec 15
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
8kwibhcmac la6
18 Dec 15
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
pl237n6
22 Oct 15
Departure of Directors or Certain Officers
12:00am
8-K
EX-10.1
zn6u7xcj9wxtkyb1yr
21 Aug 15
NEMUS Bioscience Announces Closing of $5.0 Million Series B Financing Funding to finance development of NB1111 for the treatment of glaucoma
12:00am